$PALI
PALISADE BIO, INC.

2015 Q2 Form 10-Q Financial Statement

#000114420415028586 Filed on May 08, 2015

View on sec.gov

Income Statement

Concept 2015 Q2 2015 Q1 2014 Q1
Revenue $2.500K $2.917K $4.167K
YoY Change -50.0% -30.0% -95.93%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $1.680M $1.430M $3.520M
YoY Change 10.53% -59.38% 193.33%
% of Gross Profit
Research & Development $3.313M $3.183M $1.630M
YoY Change 65.65% 95.22% -6.75%
% of Gross Profit
Depreciation & Amortization $90.00K $80.00K $90.00K
YoY Change 0.0% -11.11% 80.0%
% of Gross Profit
Operating Expenses $4.997M $4.616M $5.181M
YoY Change 42.12% -10.91% 73.03%
Operating Profit -$4.995M -$4.613M -$5.177M
YoY Change 42.25% -10.89% 79.02%
Interest Expense $459.1K $453.7K $432.7K
YoY Change 15.46% 4.85% 796.74%
% of Operating Profit
Other Income/Expense, Net -$453.3K -$440.2K -$742.2K
YoY Change -86.01% -40.69% 6.28%
Pretax Income -$5.450M -$5.050M -$5.920M
YoY Change -19.26% -14.7% 64.9%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$5.448M -$5.053M -$5.919M
YoY Change -19.3% -14.63% 64.87%
Net Earnings / Revenue -217921.48% -173230.89% -142046.0%
Basic Earnings Per Share
Diluted Earnings Per Share -$90.83M -$84.17M -$118.4M
COMMON SHARES
Basic Shares Outstanding 90.34M shares 89.70M shares 86.22M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q2 2015 Q1 2014 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $23.68M $28.63M $33.34M
YoY Change -21.67% -14.13% 163.35%
Cash & Equivalents $8.649M $13.59M $18.34M
Short-Term Investments $15.03M $15.03M $15.00M
Other Short-Term Assets $1.020M $520.0K $760.0K
YoY Change 72.88% -31.58% -13.64%
Inventory
Prepaid Expenses $904.2K $388.1K $319.6K
Receivables $18.82K $8.173K $11.36K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $24.73M $29.15M $34.11M
YoY Change -19.83% -14.53% 151.91%
LONG-TERM ASSETS
Property, Plant & Equipment $343.0K $282.1K $310.4K
YoY Change 10.62% -9.12% 47.8%
Goodwill
YoY Change
Intangibles $1.205M $1.242M $1.191M
YoY Change -3.37% 4.32%
Long-Term Investments
YoY Change
Other Assets $57.26K $59.10K $64.85K
YoY Change -2.72% -8.87% -91.69%
Total Long-Term Assets $1.647M $1.646M $1.815M
YoY Change -7.82% -9.28% -2.97%
TOTAL ASSETS
Total Short-Term Assets $24.73M $29.15M $34.11M
Total Long-Term Assets $1.647M $1.646M $1.815M
Total Assets $26.37M $30.80M $35.92M
YoY Change -19.17% -14.27% 133.12%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $2.100M $2.130M $1.770M
YoY Change 3.45% 20.34% 42.74%
Accrued Expenses $490.0K $230.0K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $3.170M $1.929M $2.850M
YoY Change 7.37% -32.31% 458.79%
Total Short-Term Liabilities $5.910M $4.336M $4.674M
YoY Change 18.4% -7.23% 76.39%
LONG-TERM LIABILITIES
Long-Term Debt $5.812M $6.955M $4.193M
YoY Change 70.15% 65.89% -40.45%
Other Long-Term Liabilities $110.0K $150.0K $160.0K
YoY Change -42.11% -6.25% 700.0%
Total Long-Term Liabilities $5.812M $6.955M $4.193M
YoY Change 70.15% 65.89% -40.62%
TOTAL LIABILITIES
Total Short-Term Liabilities $5.910M $4.336M $4.674M
Total Long-Term Liabilities $5.812M $6.955M $4.193M
Total Liabilities $11.83M $11.44M $9.027M
YoY Change 37.59% 26.7% -7.13%
SHAREHOLDERS EQUITY
Retained Earnings -$156.1M -$134.3M
YoY Change 16.2%
Common Stock $903.6K $903.4K $866.9K
YoY Change 4.06% 4.21%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $14.54M $19.36M $26.90M
YoY Change
Total Liabilities & Shareholders Equity $26.37M $30.80M $35.92M
YoY Change -19.18% -14.27% 133.12%

Cashflow Statement

Concept 2015 Q2 2015 Q1 2014 Q1
OPERATING ACTIVITIES
Net Income -$5.448M -$5.053M -$5.919M
YoY Change -19.3% -14.63% 64.87%
Depreciation, Depletion And Amortization $90.00K $80.00K $90.00K
YoY Change 0.0% -11.11% 80.0%
Cash From Operating Activities -$4.800M -$4.720M -$2.710M
YoY Change 99.17% 74.17% 7.97%
INVESTING ACTIVITIES
Capital Expenditures -$100.0K $16.05K $111.1K
YoY Change -41.18% -85.55% 6608.15%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$20.00K -$15.00M
YoY Change -99.87%
Cash From Investing Activities -$90.00K -$100.0K -$15.22M
YoY Change -47.06% -99.34% 15120.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $20.00M
YoY Change
Debt Paid & Issued, Net $0.00 $704.8K
YoY Change -100.0%
Cash From Financing Activities -40.00K 5.890M 19.43M
YoY Change -92.45% -69.69% 148.15%
NET CHANGE
Cash From Operating Activities -4.800M -4.720M -2.710M
Cash From Investing Activities -90.00K -100.0K -15.22M
Cash From Financing Activities -40.00K 5.890M 19.43M
Net Change In Cash -4.930M 1.070M 1.500M
YoY Change 58.52% -28.67% -71.26%
FREE CASH FLOW
Cash From Operating Activities -$4.800M -$4.720M -$2.710M
Capital Expenditures -$100.0K $16.05K $111.1K
Free Cash Flow -$4.700M -$4.736M -$2.821M
YoY Change 109.82% 67.88% 12.32%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-5176901 USD
CY2015Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-4612980 USD
CY2014Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
24718 USD
CY2015Q1 cur Policy For Maximum Maturity Days Of Investments Considered As Cash Equivalents
PolicyForMaximumMaturityDaysOfInvestmentsConsideredAsCashEquivalents
P90D
CY2014Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
39800000 shares
CY2013Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
8000000 USD
CY2013Q1 us-gaap Debt Instrument Unused Borrowing Capacity Amount
DebtInstrumentUnusedBorrowingCapacityAmount
2000000 USD
CY2015Q1 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.11 pure
CY2015Q1 us-gaap Debt Instrument Maturity Date
DebtInstrumentMaturityDate
2016-06-30
CY2014Q1 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
805972 shares
CY2015Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13593461 USD
CY2015Q1 us-gaap Assets
Assets
30798968 USD
CY2014Q4 us-gaap Assets
Assets
29844075 USD
CY2015Q1 cur Accounts Payable And Accrued Expenses Excluding Accrued Bonuses
AccountsPayableAndAccruedExpensesExcludingAccruedBonuses
2129199 USD
CY2014Q4 cur Accounts Payable And Accrued Expenses Excluding Accrued Bonuses
AccountsPayableAndAccruedExpensesExcludingAccruedBonuses
2504978 USD
CY2015Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
1929010 USD
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12518980 USD
CY2015Q1 us-gaap Short Term Investments
ShortTermInvestments
15032419 USD
CY2014Q4 us-gaap Short Term Investments
ShortTermInvestments
15007478 USD
CY2015Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
8173 USD
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
225524 USD
CY2015Q1 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
130677 USD
CY2014Q4 us-gaap Deferred Finance Costs Current Net
DeferredFinanceCostsCurrentNet
135694 USD
CY2015Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
388065 USD
CY2014Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
274106 USD
CY2015Q1 us-gaap Assets Current
AssetsCurrent
29152795 USD
CY2014Q4 us-gaap Assets Current
AssetsCurrent
28161782 USD
CY2015Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
282057 USD
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
301265 USD
CY2015Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1242026 USD
CY2014Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1233172 USD
CY2015Q1 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
62992 USD
CY2014Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
89143 USD
CY2015Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
59098 USD
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
58713 USD
CY2014Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
730012 USD
CY2015Q1 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
52856 USD
CY2014Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
126745 USD
CY2015Q1 us-gaap Liabilities Current
LiabilitiesCurrent
4336386 USD
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4008695 USD
CY2015Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
6954895 USD
CY2014Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
8056470 USD
CY2015Q1 us-gaap Liabilities Other Than Longterm Debt Noncurrent
LiabilitiesOtherThanLongtermDebtNoncurrent
146165 USD
CY2014Q4 us-gaap Liabilities Other Than Longterm Debt Noncurrent
LiabilitiesOtherThanLongtermDebtNoncurrent
59574 USD
CY2015Q1 us-gaap Liabilities
Liabilities
11437446 USD
CY2014Q4 us-gaap Liabilities
Liabilities
12124739 USD
CY2015Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2015Q1 us-gaap Common Stock Value
CommonStockValue
903366 USD
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
877897 USD
CY2015Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
174560069 USD
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
167890220 USD
CY2015Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
6013 USD
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
6000 USD
CY2015Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-156107926 USD
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-151054781 USD
CY2015Q1 us-gaap Stockholders Equity
StockholdersEquity
19361522 USD
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
17719336 USD
CY2015Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
30798968 USD
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
29844075 USD
CY2015Q1 us-gaap Share Based Compensation
ShareBasedCompensation
689857 USD
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
18986395 shares
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
490901 shares
CY2015Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
9935 shares
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
35065 shares
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
19432296 shares
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
15268586 shares
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
18809910 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.89
CY2015Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
3.8
CY2015Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
2.4
CY2015Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
2.4
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.94
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.03
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
1.97
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y1M6D
CY2015Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y
CY2015Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y2M12D
CY2015Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P4Y10M24D
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
2306807 USD
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
30600 USD
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
10661919 USD
CY2015Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
7816368 USD
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
10078814 USD
CY2015Q1 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
19432296 shares
CY2015Q1 cur Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerms
P5Y
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2015Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
CY2014Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.09
CY2015Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
2.38
CY2014Q1 us-gaap Share Price
SharePrice
2.91
CY2014Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
20000000 USD
CY2014Q1 cur Warrants And Shares Issued Value Net
WarrantsAndSharesIssuedValueNet
18630000 USD
CY2015Q1 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
4956000 USD
CY2015Q1 cur Compensation Expenses Unvested Restricted Stock Term Period
CompensationExpensesUnvestedRestrictedStockTermPeriod
P2Y3M18D
CY2015Q1 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
42700000 shares
CY2015Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
7000000 shares
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
7000000 shares
CY2015Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2015Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2015Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2015Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
90336643 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
87789679 shares
CY2014Q1 us-gaap Revenues
Revenues
4167 USD
CY2015Q1 us-gaap Revenues
Revenues
2917 USD
CY2014Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1630365 USD
CY2015Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3182823 USD
CY2014Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3550703 USD
CY2015Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1433074 USD
CY2014Q1 us-gaap Operating Expenses
OperatingExpenses
5181068 USD
CY2015Q1 us-gaap Operating Expenses
OperatingExpenses
4615897 USD
CY2015Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
13569 USD
CY2014Q1 us-gaap Interest Expense
InterestExpense
432741 USD
CY2015Q1 us-gaap Interest Expense
InterestExpense
453734 USD
CY2015Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
0 USD
CY2014Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-742156 USD
CY2015Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-440165 USD
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-5919057 USD
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-5053145 USD
CY2014Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.07
CY2015Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.06
CY2014Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
85750298 shares
CY2015Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
89654634 shares
CY2014Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-1264 USD
CY2015Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
13 USD
CY2014Q1 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
-5920321 USD
CY2015Q1 us-gaap Other Comprehensive Income Loss Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent
-5053132 USD
CY2014Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
90488 USD
CY2015Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
83773 USD
CY2014Q1 us-gaap Amortization Of Deferred Leasing Fees
AmortizationOfDeferredLeasingFees
224795 USD
CY2015Q1 us-gaap Amortization Of Deferred Leasing Fees
AmortizationOfDeferredLeasingFees
215182 USD
CY2014Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
334133 USD
CY2014Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1359 USD
CY2015Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-217351 USD
CY2014Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
64963 USD
CY2015Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
71207 USD
CY2014Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
0 USD
CY2015Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
357 USD
CY2014Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
492156 USD
CY2015Q1 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-375988 USD
CY2014Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
626 USD
CY2015Q1 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-3648 USD
CY2014Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-3231 USD
CY2015Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
0 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-2712824 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-4719821 USD
CY2014Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
15000000 USD
CY2015Q1 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
15032419 USD
CY2014Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
0 USD
CY2015Q1 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
15007478 USD
CY2014Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
112068 USD
CY2015Q1 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
57283 USD
CY2014Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
111087 USD
CY2015Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
16052 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-15223155 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-98276 USD
CY2014Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
1391466 USD
CY2015Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
3073537 USD
CY2014Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
113000 USD
CY2015Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
CY2014Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
19101034 USD
CY2015Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
2931925 USD
CY2014Q1 cur Payment Of Employee Taxes On Stock Option Exercise
PaymentOfEmployeeTaxesOnStockOptionExercise
426212 USD
CY2015Q1 cur Payment Of Employee Taxes On Stock Option Exercise
PaymentOfEmployeeTaxesOnStockOptionExercise
0 USD
CY2014Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
704818 USD
CY2015Q1 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
0 USD
CY2014Q1 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
40772 USD
CY2015Q1 us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
70241 USD
CY2014Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
19433698 USD
CY2015Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
5892463 USD
CY2014Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-1035 USD
CY2015Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
115 USD
CY2014Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1496684 USD
CY2015Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1074481 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
16846052 USD
CY2014Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
18342736 USD
CY2014Q1 us-gaap Interest Paid
InterestPaid
214622 USD
CY2015Q1 us-gaap Interest Paid
InterestPaid
238552 USD
CY2014Q1 cur Issuance Of Common Stock For Cashless Excercise Of Warrants And Options
IssuanceOfCommonStockForCashlessExcerciseOfWarrantsAndOptions
1073663 USD
CY2015Q1 cur Issuance Of Common Stock For Cashless Excercise Of Warrants And Options
IssuanceOfCommonStockForCashlessExcerciseOfWarrantsAndOptions
201720 USD
CY2015Q1 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
225321 USD
CY2014Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
646960 USD
CY2014Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-307411 USD
CY2015Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-421639 USD
CY2014Q1 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
1000000 USD
CY2015Q1 us-gaap Debt Instrument Periodic Payment
DebtInstrumentPeriodicPayment
300000 USD
CY2015Q1 us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
7551000 USD
CY2014Q4 us-gaap Proceeds From Debt Net Of Issuance Costs
ProceedsFromDebtNetOfIssuanceCosts
4300000 USD
CY2014Q4 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
446000 USD
CY2015Q1 us-gaap Debt Instrument Convertible Terms Of Conversion Feature
DebtInstrumentConvertibleTermsOfConversionFeature
The loan agreement provided for a conversion feature whereby the lender or the Company could each convert up to a maximum of $1 million in principal payments into common stock of the Company
CY2015Q1 dei Document Type
DocumentType
10-Q
CY2015Q1 dei Amendment Flag
AmendmentFlag
false
CY2015Q1 dei Document Period End Date
DocumentPeriodEndDate
2015-03-31
CY2015Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2015
CY2015Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2015Q1 dei Entity Registrant Name
EntityRegistrantName
Neuralstem, Inc.
CY2015Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001357459
CY2015Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2015Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2015Q1 dei Trading Symbol
TradingSymbol
CUR
CY2015Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
90336643 shares
CY2014Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
CY2015Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 USD
CY2014Q1 us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
0 USD
CY2015Q1 us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
42758 USD
CY2014Q4 cur Debt Instrument Refinanced Loan
DebtInstrumentRefinancedLoan
5600000 USD
CY2014Q4 cur Debt Instrument Principal Amount
DebtInstrumentPrincipalAmount
10000000 USD
CY2014Q4 cur Debt Instrument Additional Principal Borrowed
DebtInstrumentAdditionalPrincipalBorrowed
4400000 USD
CY2014Q4 us-gaap Long Term Debt Percentage Bearing Variable Interest Rate
LongTermDebtPercentageBearingVariableInterestRate
0.1 pure

Files In Submission

Name View Source Status
0001144204-15-028586-index-headers.html Edgar Link pending
0001144204-15-028586-index.html Edgar Link pending
0001144204-15-028586.txt Edgar Link pending
0001144204-15-028586-xbrl.zip Edgar Link pending
cur-20150331.xml Edgar Link completed
cur-20150331.xsd Edgar Link pending
cur-20150331_cal.xml Edgar Link unprocessable
cur-20150331_def.xml Edgar Link unprocessable
cur-20150331_lab.xml Edgar Link unprocessable
cur-20150331_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v408155_10q.htm Edgar Link pending
v408155_ex31-1.htm Edgar Link pending
v408155_ex32-1.htm Edgar Link pending